Mangala Hegde

1.5k total citations · 3 hit papers
51 papers, 967 citations indexed

About

Mangala Hegde is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mangala Hegde has authored 51 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Mangala Hegde's work include Curcumin's Biomedical Applications (8 papers), RNA modifications and cancer (6 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Mangala Hegde is often cited by papers focused on Curcumin's Biomedical Applications (8 papers), RNA modifications and cancer (6 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Mangala Hegde collaborates with scholars based in India, Saudi Arabia and Singapore. Mangala Hegde's co-authors include Ajaikumar B. Kunnumakkara, Sosmitha Girisa, Aviral Kumar, Uzini Devi Daimary, Gautam Sethi, Manjunath B. Joshi, Mohammed S. Alqahtani, Mohamed Abbas, Kapaettu Satyamoorthy and Bharat B. Aggarwal and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Mangala Hegde

46 papers receiving 954 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?

2023 133 citations Mangala Hegde, Sosmitha Girisa et al. profile →
Pulsed electric field (PEF): Avant-garde extraction escalation technology in food industry

2022 118 citations Aviral Kumar, Sosmitha Girisa et al. Trends in Food Science & Technology profile →
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials

2023 115 citations Ajaikumar B. Kunnumakkara, Mangala Hegde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mangala Hegde India	17	374	167	130	94	91	51	967
Hemachand Tummala United States	19	341 0.9×	98 0.6×	154 1.2×	67 0.7×	70 0.8×	31	935
Aviral Kumar India	21	512 1.4×	151 0.9×	64 0.5×	64 0.7×	217 2.4×	43	1.1k
Mohammad Jalili‐Nik Iran	18	338 0.9×	99 0.6×	72 0.6×	36 0.4×	107 1.2×	52	862
Gamaleldin I. Harisa Saudi Arabia	23	506 1.4×	60 0.4×	93 0.7×	145 1.5×	116 1.3×	88	1.5k
Do Luong Huynh South Korea	16	413 1.1×	183 1.1×	70 0.5×	83 0.9×	115 1.3×	34	1.0k
Hassan Dariushnejad Iran	17	453 1.2×	93 0.6×	135 1.0×	86 0.9×	103 1.1×	47	908
Dhanalekshmi Unnikrishnan Meenakshi India	21	450 1.2×	165 1.0×	59 0.5×	63 0.7×	217 2.4×	45	1.3k
Xinqiang Song China	16	389 1.0×	80 0.5×	146 1.1×	65 0.7×	72 0.8×	41	945
Amirhossein Davoodvandi Iran	16	419 1.1×	82 0.5×	52 0.4×	50 0.5×	174 1.9×	25	783
Susana G. Guerreiro Portugal	15	494 1.3×	81 0.5×	67 0.5×	57 0.6×	89 1.0×	34	1.4k

Countries citing papers authored by Mangala Hegde

Since Specialization

Citations

This map shows the geographic impact of Mangala Hegde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mangala Hegde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mangala Hegde more than expected).

Fields of papers citing papers by Mangala Hegde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mangala Hegde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mangala Hegde. The network helps show where Mangala Hegde may publish in the future.

Co-authorship network of co-authors of Mangala Hegde

This figure shows the co-authorship network connecting the top 25 collaborators of Mangala Hegde. A scholar is included among the top collaborators of Mangala Hegde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mangala Hegde. Mangala Hegde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Girisa, Sosmitha, Mangala Hegde, Mohammed S. Alqahtani, et al.. (2025). Restoring FXR expression as a novel treatment strategy in liver cancer and other liver disorders. Expert Opinion on Therapeutic Targets. 29(4-5). 193–221. 5 indexed citations

Hegde, Mangala, et al.. (2025). Exosomal dynamics: Bridging the gap between cellular senescence and cancer therapy. Mechanisms of Ageing and Development. 225. 112045–112045. 1 indexed citations

Hegde, Mangala, et al.. (2025). Nanoformulations: Reforming treatment for non-small cell lung cancer metastasis. Biochemical Pharmacology. 238. 116928–116928.

Hegde, Mangala, Sosmitha Girisa, Mohammed S. Alqahtani, et al.. (2024). Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics. Life Sciences. 351. 122786–122786. 1 indexed citations

Alqahtani, Mohammed S., Mohamed Abbas, Mangala Hegde, et al.. (2024). Exploring the nexus of nuclear receptors in hematological malignancies. Cellular and Molecular Life Sciences. 81(1). 78–78. 9 indexed citations

Hegde, Mangala, et al.. (2024). Ellagic Acid-Gold Nanoparticle Complex as Anticancer Agent in Triple-Negative Breast Cancer Cells. Nano LIFE. 14(2). 2 indexed citations

Hegde, Mangala, et al.. (2024). Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases. Military Medical Research. 11(1). 67–67. 11 indexed citations

Hegde, Mangala, Aviral Kumar, Sosmitha Girisa, et al.. (2024). Biogenic Synthesis and Characterization of Ethyl Ferulate Gold Nanoparticle and its Efficacy against Triple-Negative Breast Cancer Cells. 15(1). 80–94. 1 indexed citations

Kumar, Aviral, Juncheng Lyu, Mangala Hegde, et al.. (2024). Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management. Journal of Biomedical Science. 31(1). 105–105. 4 indexed citations

10.

Hegde, Mangala, et al.. (2023). Curcumin, inflammation, and neurological disorders: How are they linked?. Integrative Medicine Research. 12(3). 100968–100968. 39 indexed citations

11.

Kumar, Aviral, Sosmitha Girisa, Mohammed S. Alqahtani, et al.. (2023). Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics. Cells. 12(5). 810–810. 22 indexed citations

12.

Hegde, Mangala, Uzini Devi Daimary, Aviral Kumar, et al.. (2022). Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment. Phytomedicine. 105. 154369–154369. 19 indexed citations

13.

Khatoon, Elina, Mangala Hegde, Aviral Kumar, et al.. (2022). The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Archives of Pharmacal Research. 45(8). 507–534. 13 indexed citations

14.

Hegde, Mangala, Sosmitha Girisa, Mohammed S. Alqahtani, et al.. (2022). Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases. Biomolecules. 12(9). 1185–1185. 46 indexed citations

15.

Hegde, Mangala, Uzini Devi Daimary, Arunachalam Chinnathambi, et al.. (2022). Differential Expression of Genes Regulating Store-operated Calcium Entry in Conjunction With Mitochondrial Dynamics as Potential Biomarkers for Cancer: A Single-Cell RNA Analysis. Frontiers in Genetics. 13. 866473–866473. 3 indexed citations

16.

Kumar, Aviral, et al.. (2022). Pulsed electric field (PEF): Avant-garde extraction escalation technology in food industry. Trends in Food Science & Technology. 122. 238–255. 118 indexed citations breakdown →

17.

Kumar, Aviral, Mangala Hegde, Mohammed S. Alqahtani, et al.. (2022). Interplay of dietary antioxidants and gut microbiome in human health: What has been learnt thus far?. Journal of Functional Foods. 100. 105365–105365. 35 indexed citations

18.

Hegde, Mangala & Ajaikumar B. Kunnumakkara. (2022). 28P ACLY-mediated breast tumorigenesis is driven by immune escape via PD-L1 signaling. Annals of Oncology. 33. S136–S136.

19.

Hegde, Mangala, Kanive Parashiva Guruprasad, Lingadakai Ramachandra, Kapaettu Satyamoorthy, & Manjunath B. Joshi. (2020). Interleukin-6–mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors. Journal of Biological Chemistry. 295(34). 12086–12098. 29 indexed citations

20.

Hegde, Mangala, et al.. (2015). Serum Levels of L-amino Acid Oxidase in Ovarian Cancer Patients. 3(1). 105–112. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact